WGSWW vs. ACONW, BTSGU, BFRGW, CCLDP, CCLDO, CMAXW, EUDAW, BEATW, LFMDP, and LIFWZ
Should you be buying GeneDx stock or one of its competitors? The main competitors of GeneDx include Aclarion (ACONW), BrightSpring Health Services (BTSGU), Bullfrog AI (BFRGW), CareCloud (CCLDP), CareCloud (CCLDO), CareMax (CMAXW), EUDA Health (EUDAW), HeartBeam (BEATW), LifeMD (LFMDP), and MSP Recovery (LIFWZ). These companies are all part of the "health information services" industry.
GeneDx (NASDAQ:WGSWW) and Aclarion (NASDAQ:ACONW) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, analyst recommendations, profitability, dividends, earnings and community ranking.
In the previous week, GeneDx had 1 more articles in the media than Aclarion. MarketBeat recorded 3 mentions for GeneDx and 2 mentions for Aclarion. GeneDx's average media sentiment score of 0.00 beat Aclarion's score of -0.27 indicating that GeneDx is being referred to more favorably in the media.
GeneDx and Aclarion both received 0 outperform votes by MarketBeat users.
Summary
GeneDx beats Aclarion on 3 of the 3 factors compared between the two stocks.
Get GeneDx News Delivered to You Automatically
Sign up to receive the latest news and ratings for WGSWW and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding WGSWW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
WGSWW vs. The Competition
Related Companies and Tools
